nitroaspirin has been researched along with oxadiazoles in 2 studies
| Studies (nitroaspirin) | Trials (nitroaspirin) | Recent Studies (post-2010) (nitroaspirin) | Studies (oxadiazoles) | Trials (oxadiazoles) | Recent Studies (post-2010) (oxadiazoles) |
|---|---|---|---|---|---|
| 127 | 9 | 8 | 6,057 | 257 | 2,359 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Degan, M; Gaino, S; Lechi, A; Meneguzzi, A; Minuz, P; Santonastaso, CL; Soldato, PD; Zuliani, V | 1 |
| Cena, C; Fruttero, R; Gasco, A; Megson, IL; Rossi, AG; Turnbull, CM | 1 |
2 other study(ies) available for nitroaspirin and oxadiazoles
| Article | Year |
|---|---|
NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes.
Topics: Aspirin; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibrinolytic Agents; Guanylate Cyclase; Humans; Interleukin-6; Lipopolysaccharides; Monocytes; Nitric Oxide; Oxadiazoles; Quinoxalines; Thromboplastin; Thromboxane B2; Tumor Necrosis Factor-alpha | 2001 |
Mechanism of action of novel NO-releasing furoxan derivatives of aspirin in human platelets.
Topics: Adult; Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Humans; Middle Aged; Nitric Oxide; Nitric Oxide Donors; Oxadiazoles; Platelet Aggregation; Salicylic Acid | 2006 |